Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 23, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...
Webcast to be held Monday, March 23rd at 8:00 a.m. ET. SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biot ...
One of these assets is catalyst-driven; the other isn't.
Arcellx Inc. is set to report full-year 2025 results Monday, potentially its final earnings release as an independent company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results